Dr. Charalampos Lazaris is a member of the Oncology Data Science team at Novartis Biomedical Research in Cambridge, MA. He explores mechanisms of transcriptional regulation in order to uncover cancer vulnerabilities and target them therapeutically. He earned his Ph.D. at the NYU School of Medicine, under the supervision of Drs. Iannis Aifantis and Aristotelis Tsirigos. During his Ph.D., he focused on genetic alterations of topologically associating domain (TAD) boundaries and their link with aberrant oncogene activation in T-cell acute lymphoblastic leukemia, a type of blood cancer common in children. He completed postdoctoral work at the USC Keck School of Medicine and the Whitehead Institute (MIT). He was also an Associated Scientist at the Klarman Cell Observatory of the Broad Institute of MIT and Harvard. While at Broad Institute, he served as a vice-chair of the NextGen Association. He currently serves as the President of the New York University Graduate School of Arts and Science Doctoral Alumni Association (DAA).
Ph.D. in Systems & Computational Biomedicine, 2018
New York University (NYU)
MS in Systems & Computational Biomedicine, 2016
New York University (NYU)
MS in Bioinformatics, 2012
University of Edinburgh
MS in Molecular Biology-Biomedicine, 2009
University of Crete
MS in Biological Applications and Technologies, 2005
University of Ioannina
Responsibilities include:
Responsibilities include:
Regulation of biological processes typically incorporates mechanisms that initiate and terminate the process and, where understood, these mechanisms often involve feedback control. Regulation of transcription is a fundamental cellular process where the mechanisms involved in initiation have been studied extensively, but those involved in arresting the process are poorly understood. Modeling of the potential roles of RNA in transcriptional control suggested a non-equilibrium feedback control mechanism where low levels of RNA promote condensates formed by electrostatic interactions whereas relatively high levels promote dissolution of these condensates. Evidence from in vitro and in vivo experiments support a model where RNAs produced during early steps in transcription initiation stimulate condensate formation, whereas the burst of RNAs produced during elongation stimulate condensate dissolution. We propose that transcriptional regulation incorporates a feedback mechanism whereby transcribed RNAs initially stimulate but then ultimately arrest the process. Copyright o̧pyright 2020 Elsevier Inc. All rights reserved.
Cellular transformation is accompanied by extensive rewiring of many biological processes leading to augmented levels of distinct types of cellular stress, including proteotoxic stress. Cancer cells critically depend on stress-relief pathways for their survival. However, the mechanisms underlying the transcriptional initiation and maintenance of the oncogenic stress response remain elusive. Here, we show that the expression of heat shock transcription factor 1 (HSF1) and the downstream mediators of the heat shock response is transcriptionally upregulated in T cell acute lymphoblastic leukemia (T-ALL). Hsf1 ablation suppresses the growth of human T-ALL and eradicates leukemia in mouse models of T-ALL, while sparing normal hematopoiesis. HSF1 drives a compact transcriptional program and among the direct HSF1 targets, specific chaperones and co-chaperones mediate its critical role in T-ALL. Notably, we demonstrate that the central T-ALL oncogene NOTCH1 hijacks the cellular stress response machinery by inducing the expression of HSF1 and its downstream effectors. The NOTCH1 signaling status controls the levels of chaperone/co-chaperone complexes and predicts the response of T-ALL patient samples to HSP90 inhibition. Our data demonstrate an integral crosstalk between mediators of oncogene and non-oncogene addiction and reveal critical nodes of the heat shock response pathway that can be targeted therapeutically.